The new SPAC intends to acquire a business based in Asia (excluding China, Hong Kong, and Macau) that is developing breakthrough technology in life sciences or advancing a platform for sustainable technology. Valuence Merger Corp. I is led by CEO Sung Yoon Woo, CFO Sungwoo (Andrew) Hyung, President Sungsik (Sung) Lee, and COO Dr. Gene Young Cho.
Total SPAC deal count for 2022 year-to-date is now 45. This offering is expected to close on Thursday, March 3.
SVB Leerink is acting as sole book-running manager for the offering and Baird is acting as the lead manager of the offering. Sheppard, Mullin, Richter & Hampton LLP is serving as Issuer’s Counsel with Davis Polk & Wardell LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as an auditor. Continental Stock Transfer & Trust Company is acting as trustee.